Elvira Llaneza Suárez ( FICYT ), nurse, member of the CARE4DIABETES Coordination Team, and Cristina Álvarez Cuadrado ( #SESPA ), specialist in Family and Community Medicine, project participant of the Regional Health Ministry of Asturias, attended the 4th National Diabetes Congress of the redGDPS Foundation, held in Valencia on 27–28 November 2025.
Presentation of Preliminary Results: Participant Satisfaction Across Five Spanish Regions
During the conference, the team presented preliminary findings on participant satisfaction from the C4D programme implemented across five regions in Spain.
Participants completed the DTSQ-status version (DTSQs) at baseline and the DTSQ-change version (DTSQc) at 12 months.
- A total of 91 individuals with type 2 diabetes (T2D) took part in the first C4D pilot in Spain;
- 54.9% (n=50) were women;
- All participants were using at least one antihyperglycemic medication;
- The mean age was 60.2 ± 9 years, with an average diabetes duration of 5.2 ± 3.1 years;
- Baseline HbA1c was 6.63 ± 1%.;
- The mean DTSQs global score at baseline was 28 ± 8.
After the educational intervention, participants reported a clear improvement in treatment satisfaction compared to their previous therapy, with a mean DTSQc score of 11.3 ± 5.9.
Notably, 15 participants (16.5%) completed the programme using lifestyle-only treatment. HbA1c at 12 months averaged 6.46 ± 1%.
These results suggest that structured, group-based education for T2D—delivered by a multidisciplinary team—significantly enhances treatment satisfaction. By empowering individuals to play an active and informed role in therapeutic decision-making, the C4D pilot highlights the value of patient-centred education in improving outcomes for people with type 2 diabetes. .
The Retina as a Mirror of Change: Impact of an Integrated Approach in Diabetes
Another presentation showcased the importance of a comprehensive, multidisciplinary, and lifestyle-focused approach in managing microvascular complications of diabetes.
The case illustrated how combining pharmacological therapy with structured lifestyle modification can improve glycemic control, slow the progression of diabetic retinopathy, reduce treatment burden, and strengthen patient autonomy.
